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Abstract 
Here, cluster analysis showed that a database of 158 peptides formed 21 clusters 
based on net positive charge, hydrophobicity and amphiphilicity. In general these 
clusters showed similar median toxicities (p = 0.176) against eukaryotic cell lines and 
no single combination of these properties was found optimal for efficacy. The 
database contained 14 peptides, which showed selectivity for tumour cell lines only 
(ACPCT), 123 peptides with general toxicity to eukaryotic cells (ACPGT) and 21 
inactive peptides (ACPI). Hydrophobic arc size analysis showed that there was no 
significant difference across the datasets.  Even though there was no correlation there 
was no correlation observed, peptides with wide hydrophobic arcs (> 270°) appeared 
less toxic. Extended hydrophobic moment plot analysis predicted that over 50% of 
ACPCT and ACPGT peptides would be surface active, which led to the suggestion that 
amphiphilicity is a key driver of the membrane interactions for these peptides but 
probably plays a role in their efficacy rather than their selectivity. This analysis also 
predicted that only 14% of ACPCT peptides compared to 45% of ACPGT peptides were 
candidates for tilted peptide formation. This implies that those peptides with non-
specific activity may have a tendency towards the utilisation of membrane disruptive 
structures such as tilt peptides which led to the suggestion that the absence of this 
structure may support cancer cell selectivity. However, these analyses predicted that 
ACPI peptides, which possess no anticancer activity, would also form surface active 
and tilted α-helices, clearly showing that other factors are involved in determining the 
efficacy and selectivity of ACPs.  
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Introduction  
Defence peptides are naturally occurring antimicrobial molecules and many have been 
found to possess toxicity to tumour cells. However, these anticancer peptides (ACPs) 
differ widely in their efficacy and selectivity for cancer cells. Some ACPs exhibit 
general toxicity (ACPGT peptides) to eukaryotic cells, killing cancer and non-cancer 
alike, whilst others show toxicity to cancer cells alone (ACPCT peptides). Moreover, 
ACPCT peptides can also show selectivity between different types of cancer cells. At 
present, the factors that determine these differences in efficacy and selectivity are 
poorly understood, limiting efforts to develop ACPs as therapeutically useful 
anticancer agents [1, 2]. 
 
Current understanding is that the efficacy and selectivity of ACPs for cancer cells is 
dependent upon their ability to interact with membranes of the target cells. This 
ability appears to depend upon the characteristics of the target cell membrane along 
with a range of physiochemical properties possessed by ACPs with net positive 
charge, amphiphilicity and hydrophobicity making major contributions [3]. These 
physiochemical properties are determined by amino acid composition and the 
secondary structure adopted by the parent molecule with the majority of studies 
involving peptides that adopt amphiphilic α-helical structure [3].  Many of these 
peptide α-helices may be classed as surface active and interact with the bilayer such 
that their orientation is approximately parallel to the membrane surface albeit, 
sometimes, as an initial step leading to further membrane interactions or cell 
internalisation.  Adopting such orientations allows the polar face of these α-helices to 
interact with the bilayer head group region whilst their polar face penetrates the 
hydrophobic membrane core [4]. However, it is becoming increasingly clear that a 
number of ACPs adopt membrane interactive oblique orientated α-helical structure 
[5-7]. Also known as tilted peptides, these are a highly specialised class of 
amphiphilic α-helix that show some structural similarities to surface active α-helices 
but differ primarily by possessing an asymmetric distribution of hydrophobicity along 
the α-helical long axis. This structural feature facilitates membrane penetration by the 
segment at a shallow angle of between 30o and 60o, thereby inducing a range of 
membrane - related effects such as the destabilisation of lipid packing [8, 9].  
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To date, few large scale databases of ACPs appear to have been presented, limiting 
the potential for theoretical investigations into factors that influence the anticancer 
activity of these peptides. However, Owen et al., [10] recently introduced an 
extensive database of naturally occurring and synthetic α-helical ACPs and in the 
present study, we have used a variety of theoretical techniques to identify factors that 
may contribute to differences in the efficacy and selectivity of these peptides.  
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Methods 
Database assembly 
A database of anticancer peptides (ACPs) was constructed using data presented by 
Owen et al., [10] and α-helical structure in these peptides was confirmed using the 
secondary structure prediction programme: Profile Network from Heidelberg [11]. 
Toxicity data for these ACPs were also extracted from the database of Owen et al., 
[10] as the half lethal dose (LD50) against WI38 - a normal fibroblast cell line of the 
lung diploid cells, MCF7 - a breast adenocarcinoma tumour cell line, SW480 - a colon 
adenocarcinoma tumour cell line, BMKC - a cloned melanoma cell line, H1299 - a 
lung large cell carcinoma tumour cell line, HeLaS3 - a cervical epithelial carcinoma 
cell line and PC3 – a prostate adenocarcinoma tumour cell lines. Based on these 
toxicity data, the dataset of ACPs was further divided into 3 subsets, which included: 
14 peptides which showed selectivity for tumour cell lines only (ACPCT), 123 
peptides with general toxicity to eukaryotic cells (ACPGT) and 21 inactive peptides 
(ACPI). 
 
Extended hydrophobic moment plot analysis 
After removal of peptides < 11 residues, peptides in each of the ACPGT, ACPCT and 
ACPI datasets were analysed using extended hydrophobic moment plot methodology 
[12]. According to this methodology, the hydrophobicity of successive amino acids in 
these sequences are treated as vectors and summed in two dimensions, assuming an 
amino acid side chain periodicity of 100°. The resultant of this summation, the 
hydrophobic moment (µH) provides a measure of α-helix amphiphilicity [13]. Our 
analysis used a moving window of 11 residues and for each sequence under 
investigation the window with the highest hydrophobic moment was identified. For 
these windows, the mean hydrophobic moment, < µH >, and the corresponding mean 
hydrophobicity, < H >, which provides a measure of α-helix affinity for the membrane 
interior, were computed using the normalised consensus hydrophobicity scale of 
Eisenberg et al., [14]. For each of these datasets, these parameters were then plotted 
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on the extended hydrophobic moment plot diagram of Harris et al., [12] and the 
location of the data points used to identify sequences that were predicted to be surface 
active, globular, transmembrane or candidates to form tilted peptides 
 
Cluster analysis of ACPs 
 Identification of clusters 
For peptides in the ACP dataset, the net positive charge was determined along with < 
µH > and < H >, which were computed as described above. Three-dimensional 
clustering of the dataset was performed using the statistical unweighted pair group 
arithmetic averaging (UPGMA), methodology, which is an agglomerative hierarchical 
technique [15]. The UPGMA tree was reconstructed using Phylip v3.63 
(http://evolution.genetics.washington.edu) with the results presented in the form of a 
dendrogram. As part of the pair-wise algorithmic process, Euclidean distances 
between the data points in multi-dimensional space were used to construct an un-
rooted tree together with joining nodes forming a branch. The peptides were clustered 
according to net positive charge, <H> and <µH>, and were considered as part of a 
cluster when the ACPs, were linked to other ACPs by a maximum of two nodes.   
 
Toxicity analysis of clusters 
The cell line toxicities of ACPs within clusters were subjected to box plot analysis in 
order to observe any outliers. This analysis was also used to determine the range of 
toxicities shown by peptides in each cluster and to enable comparison of the toxicities 
between clusters. The efficacy of ACPs in each cluster was studied using the cell 
lines: W138, MCF7, SW480, BMKC, H1299, HeLaS3 and PC3. To statistically 
compare the cell line toxicities of ACPs between clusters, the Anderson-Darling test 
was applied to investigate the normal distribution of the data. If p < 0.005, the data 
were considered to be non-normally distributed, in which case the Kruskal-Wallis 
non-parametric test was applied to test the null hypothesis (H0) that there was no 
significant difference (p > 0.05) between cell line toxicities for the clusters analysed. 
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Results 
Using UPGMA cluster analysis a dendrogram of ACPs in the database was 
constructed, which grouped peptides with similar net positive charge, < H > and < μH 
>. This analysis produced 1 tree, which was congruent in nodes showing 21 peptide 
clusters that demonstrated similarities in these physiochemical properties. These 
clusters of ACPs were designated A to U and in order to observe if any given 
arrangement of net positive charge, <μH> and < H > maximised the efficacy of ACPs, 
a box plot was used to represent the toxicity values for peptides within each cluster.  
In the case of the fibroblast cell line, W138 (Figure 1), the non-parametric test, 
Kruskal-Wallis, confirmed that there was a significant difference between medians 
across the range of clusters (Kruskal-Wallis = 38.261; p = 0.005). Further analysis of 
Figure 1 showed that the medians for clusters J and U were higher than those of the 
other clusters but that there were no significant difference between the medians of the 
remaining clusters (Kruskal-Wallis = 21.074; p = 0.176). 
 
A box plot was used to represent the toxicity values for peptides within each cluster 
for each of the different cancer cell lines investigated (Figure 2).  The Kruskal-Wallis 
test confirmed that there was a significant difference between the medians across the 
range of clusters for MCF7 (Kruskal-Wallis = 36.44; p = 0.009), SW480 (Kruskal-
Wallis = 31.21; p = 0.027) and BMKC (Kruskal-Wallis = 36.17; p = 0.01).  Further 
analysis of Figure 2 showed that for MCF7, SW480 and BMKC the median for 
clusters J, P, Q and U were higher than those of the other clusters.  When these 
clusters are removed from the analysis there is no significant difference between the 
medians for the remaining clusters (MCF7 Kruskal-Wallis = 15.08; p = 0.446, SW480 
Kruskal-Wallis = 16.02; p = 0.312 and BMKC Kruskal-Wallis = 14.46; p = 0.491).  
There was no significant difference between the medians across the range of clusters 
for the remaining cell lines H1229 (Kruskal-Wallis = 19.89; p = 0.401), HeLaS3 
(Kruskal-Wallis = 26.28; p = 0.123) and PC3 (Kruskal-Wallis = 28.29; p = 0.007).  
 
The box plot in Figure 2 also showed that peptides in clusters J and U are less 
effective across all cell lines.  The peptides in these clusters had wide hydrophobic arc 
sizes ~ 220° implying that a wide hydrophobic arc reduced toxicity. Further statistical 
analysis of hydrophobic arc sizes for the complete dataset was undertaken and 
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represented as a boxplot in Figure 3.  These data showed that the hydrophobic arc size 
of the ACPI, ACPCT and ACPGT peptides ranged from 60° to 260° with ACPGT 
peptides possessing the widest range (60° to 260°) and ACPCT peptides possessing the 
narrowest range (80° to 240°) but the median arc size showed no significant 
difference (Kruskal Wallis =  0.01; p = 0.997). The database of ACPs was then 
interrogated and for each member peptide, its hydrophobic arc size along with its 
toxicity values (LD50) against the 7 cell lines studied were extracted, collated and 
plotted on Cartesian planes to produce scatter plots (Figure 4).  Whilst regression 
analysis of these data using the method of least squares showed that there was no 
statistical linear relationship between these two parameters (R2 = 0.03), Figure 4 does 
indicate that in general peptides with arc sizes > 270° were less toxic with no toxicity 
values < 500 µM in contrast to peptides from all other arc sizes.   
 
Peptides in each of the ACPCT, ACPGT and ACPI datasets were analysed according to 
extended hydrophobic moment plot methodology [12].  For the ACPs of each of these 
datasets, plots of < μH > versus < H > were then constructed and according to the 
location of their data points on the plot diagram (Figure 5, A-C), peptides were 
defined as potentially either: surface active, globular or tilted [5]. This analysis 
predicted that 7 of the ACPI peptides were surface active with 6 potentially able to 
form tilted peptides. The remaining 2 ACPI peptides were predicted to be globular 
(Figure 5A). This analysis also predicted that 4 ACPCT peptides were surface active 
with 1 showing the potential to adopt tilted structure. The remaining 2 ACPCT 
peptides were predicted to be globular (Figure 5B). ACPGT peptides represented the 
biggest single group of ACPs in the database and 57 of these peptides were predicted 
to be surface active. The remaining ACPGT peptides included 49 that were candidates 
to form tilted peptides and 4 that showed the potential to be globular (Figure 5C). 
These data are summarised in Table 1. 
 
Given the apparent importance of surface activity the level of amphiphilicity was 
further investigated.  Figure 5 showed that the  < μH > of the ACPI, ACPGT and 
ACPCT datasets ranged from 0.33 to 1.05. The widest range in the < μH > was 
observed for the ACPGT peptides (0.33 to 1.05) and the narrowest range in < μH > was 
observed for the ACPCT peptides (0.53 to 0.78).  Comparison of the medians across 
the dataset showed that the median < μH > for ACPGT was 0.74, which was greater 
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than the median of ACPI (median = 0.71) and ACPCT (median = 0.73) peptide datasets.  
Since there was evidence of non-normality in the < μH > values of peptides in the 
datasets (Anderson-Darling = 6.315, p < 0.005), the non-parametric test, Kruskal-
Wallis, was used to test the null hypothesis that the medians were the same across the 
3 datasets. Here, the null hypothesis was accepted, confirming that there was no 
significant difference between the < μH > medians of the ACPI, ACPCT and ACPGT 
peptides (Kruskal Wallis = 4.391; p = 0.11).  
 
 
Discussion 
At present, the factors that determine differences in the efficacy and selectivity of 
ACPs are poorly understood, inhibiting the potential to develop these peptides as 
therapeutically useful anticancer agents [1, 2]. However, it is generally accepted that 
net positive charge, hydrophobicity and amphiphilicity play major roles in the 
anticancer action of ACPs [1] and here, theoretical analyses are used to study the 
contribution of these physiochemical properties to the efficacy and selectivity of these 
peptides. 
 
Owen et al., [10] recently introduced an extensive database of α-helical ACPs, which 
included sequence information and toxicity data for a variety of cancer cell lines. 
Here, three-dimensional clustering techniques [15], were used to group ACPs of this 
database with similar net positive charge, < H > and < μH >, which produced 21 
clusters, A to U. Box plots of these clusters were constructed for each cell line studied 
and in all cases, toxicities to fibroblast and cancer cell lines were in the low 
micromolar range (Figure 1 and 2). These box plot analyses also showed that in the 
vast majority of cases, clusters showed similar median cell line toxicities (p = 0.176) 
and examination of Figures 1 and 2 showed that no single combination of these 3 
properties seemed to increase the overall efficacy of the ACPs analysed.  
 
The hydrophobic arc sizes  of the peptides in the ACP database ranged between 60° 
and 260°, which is comparable to those observed by Dennison et al., [3] for ACPs 
(20° to 240°).  Figure 4  indicates that in general peptides with arc sizes > 270° were 
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less toxic (MIC values > 500 µM) in contrast to peptides from all other arc sizes.  
However, whilst less active clusters appeared to have wider arc size, statistical 
analysis could find no direct correlation between arc size and toxicity. Nonetheless, it 
is generally accepted that hydrophobicity is a key driver of the ability of ACP peptides 
to penetrate membranes and hence their anticancer action [3].  Thus, the fact that 
ACPI and ACPGT peptides have similar hydrophobic arc sizes to ACPCT peptides 
clearly suggests that although these physiochemical properties are important to the 
anticancer action of these latter peptides, other factors must be involved. 
 
In response, we have used < H > and < μH > along with extended hydrophobic 
moment plot methodology to consider the impact of the overall molecular architecture 
on the membrane interactive potential of peptides in the ACPGT, ACPCT and ACPI 
datasets. Use of this methodology predicted that 56% of these ACPCT peptides and 
52% of these ACPGT peptides would be surface active (Figure 5, B and C), which is 
consistent with previous work where it was predicted that surface activity may play an 
important role in the membrane interactions of ACPs [1]. Moreover, these results 
clearly suggest that amphiphilicity is a key driver of the membrane interactions of 
over half the peptides in the dataset and given its importance to both ACPCT and 
ACPGT peptides, it probably plays a role in the efficacy of the peptides against target 
cells rather than their selectivity. Extended hydrophobic moment plot analysis further 
showed that 14% of the ACPCT peptides and 45% of the ACPGT peptides studied were 
candidates for oblique orientated α-helix formation (Figure 5, C). Although the 
ACPCT dataset is small, these results would seem to indicate that in contrast to ACPCT 
peptides, membrane interaction of ACPGT peptides may more commonly utilise tilted 
peptide structure. Thus, it may be that use of oblique orientated α-helical structure by 
ACPGT peptides is associated with their broader spectrum of target specificity as 
compared to ACPCT peptides. This structure has been associated with relatively non-
specific means of cell lysis [1], which would fit this suggestion. 
 
In the case of amphiphilicity, comparisons across the ACPI, ACPAO and ACPT 
datasets suggested that there may be an optimal range of values between 0.33 and 
1.05, which is in close in agreement with that obtained by Dennison et al., [3],  
indicating their high potential as surface active compounds This architecture is 
required for their ability to interact with the hydrophobic section of a cancer cell 
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membrane, whilst the charged residues remain in contact with the anionic 
phospholipids on the outer surface, thus ensuring their aggregation onto the surface 
consequently leading to membrane permeabilization [16, 17]. Statistical analysis 
showed that there were significant differences between the < μH > values of peptides 
across the ACPI, ACPCT and ACPGT datasets although those peptides showing cancer 
cell specificity fell within a narrow range of amphiphilicity (0.53-0.78) 
 
In summary, amphiphilicity appears to be a key driver in the efficacy of most ACPCT 
peptides and circa half the ACPGT peptides studied here against cell lines. The 
adoption of oblique orientated α-helical structure by many of the remaining ACPGT 
peptides may be important to their broad spectrum activity. However, it can be seen 
from Figure 3A and Table 1 that peptides of the ACPI dataset, which possess no 
anticancer activity, would also be predicted to form surface active and tilted α-helices. 
This is an important result in that it clearly shows that other factors are involved in 
determining the efficacy and selectivity of ACPCT and ACPGT peptides and strongly 
supports our previous work where it was suggested that the anticancer activity of 
ACPs was determined by the interplay of a range of physiochemical characteristics 
rather than any single over riding factor [3]. 
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Figure 1. Peptides were grouped by net positive charge, < µH > and < H >, as described in the methods 
to form clusters A to U.  For each cluster box plot analysis of the toxicity of ACPs when directed 
against the W138 cell line is shown. The dark band within each plot indicates median toxicity of the 
ACPs analysed and positive outliers are annotated (×) are Shive10 AC in cluster A, Modelin-5-COOH 
in cluster G and FLAK50T8 in cluster I.  
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Figure 2 
 
Figure 2. Peptides were grouped by net positive charge, < µH > and < H >, as described in the methods 
to form clusters A to U.  For each cluster box plot analysis of the toxicity of ACPs when directed 
against the different cell line is shown. The dark band within each plot indicates median toxicity of the 
ACPs analysed and positive outliers are annotated (×).  
 
 
  
15 
 
Figure 3: The hydrophobic arc size of peptides within the ACPI, ACPCT and ACPGT 
datasets were subjected to box plot analysis. The plot shows the median hydrophobic 
arc size (dark band) along with the minimum and maximum hydrophobic arc size. 
The box represents the lower (Q1 = 25%) and upper (Q3 = 75%) quartile range of 
hydrophobic arc size.  
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Figure 4 Shown above is a plot of hydrophobic arc size versus the toxicity (LD50) of 
ACPs in the database for the combined number of cell lines investigated, which were: 
WI38, MCF7, SW480, BMKC, H1299, HeLaS3 and PC3 
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Figure 5 
 
Figure 5. Shown above is extended hydrophobic moment plot analysis of peptides  in the ACPI (A), 
ACPCT (B) and ACPGT (C) datasets. It can be seen that these data points are mainly distributed over the 
area predicting surface activity and the shaded area, which identifies candidates for oblique orientated 
α-helix formation.   
 
18 
 
 
Predicted protein type ACPI ACPCT ACPGT 
Surface active 7 4 57 
Globular 2 2 4 
Tilted 6   1 49 
 
Table 1. Summarised above are the classification of peptides > 11 residues in the ACPI, ACPCT and 
ACPGT datasets (Figure 7, A-C) when analysed according to extended hydrophobic moment plot 
methodology, all as described above. 
 
 
